Background: Though decreased baroreceptor refl ex sensitivity (BRS) promotes cardiovascular (CV) morbidity and CV risks are reported in the fi rst-degree relatives (FDR) of Type 2 diabetics, the pathophysiological mechanisms contributing to CV risks in these subjects are not yet elucidated. Methods and Results: Body mass index (BMI), CV parameters such as heart rate (HR), blood pressure (BP), rate-pressure product (RPP), stroke volume (SV), left-ventricular ejection time (LVET), cardiac output, total peripheral resistance (TPR) and BRS, spectral-indices of heart rate variability (HRV), autonomic function tests (AFT) and fasting blood glucose (FBG) were measured and analyzed in subjects of the study group (FDR of Type 2 diabetics, n = 79) and control group (subjects with no family history of diabetes, n = 115). BMI, HR, BP, RPP, SV, LVET, cardiac output, TPR, low-frequency to the high-frequency ratio (ratio of LF-HF power of HRV) and FBG were increased (P < 0.0001), and BRS was decreased (P < 0.0001) in the study group compared to the control group. AFT and HRV parameters demonstrated sympathovagal imbalance (SVI) in the study group, which was due to concomitant sympathetic activation and vagal inhibition. There was a signifi cant correlation of BRS with BMI, CV parameters and LF-HF ratio, a sensitive marker of SVI. Multiple-regression analysis demonstrated independent contribution LF-HF ratio and hypertension status to BRS in the study group. Bivariate-logistic regression revealed signifi cant prediction (odds ratio: 2.15; confi dence interval: 1.1112-6.856, P = 0.008) of BRS to increased RPP, the marker of CV risk, in the study group. Conclusion: Decreased BRS in FDR of Type 2 diabetics predisposes them to CV dysfunction. BRS is linked to SVI and CV risks in these high-risk subjects.
INTRODUCTION
Recently, it has been reported that cardiovascular diseases (CVD) and diabetes mellitus are quite prevalent in younger age group in developing countries, especially in Indian sub-continent. 1, 2 Diabetes and CVD share many common risk factors and the risk for mortality escalates with the cooccurrence of diabetes and CVD. 3 Hence, early detection and treatment of diabetes, especially at a younger age is among the major strategies to prevent the occurrence of CVD in the general population. 4 In general, the fi rst-degree relatives (FDR) of diabetic patients are more prone to develop diabetes, 5 and the CV risks and prevalence of CVD are more in this high-risk population. 6, 7 However, until date, no study has been conducted to elucidate the physiological mechanisms that predispose the FDR of Type 2 diabetics to increased CV risks.
Sympathovagal imbalance (SVI) has recently been reported to be associated with CV morbidities in different clinical
Original Article conditions. 8, 9 SVI has also been proposed as the physiologic basis of metabolic derangements in diabetes mellitus. 10, 11 An earlier study has reported autonomic imbalance with sympathetic hyperactivity in FDR of diabetic patients. 12 Though autonomic dysregulation has been reported in FDR of Type 2 diabetics, 12, 13 the physiological basis of increased CV risks and contribution of autonomic imbalance to these risks in these subjects have not been studied. Recently, we have reported SVI in the form of sympathetic overactivity and vagal inhibition and the association of SVI with CV risks in FDR of Type 2 diabetics.
14 However, in this study, we had assessed CV risks without assessing CV dysfunctions.
Recently, spectral analysis of heart rate variability (HRV) has been documented as a tool for assessment of autonomic dysfunction in health and diseases. 15 Baroreceptor refl ex sensitivity (BRS) assessed by continuous blood pressure variability (BPV) monitoring has long been established as a sensitive measure of SVI. 16 Furthermore, the BPV assessed by Finapres method records various CV parameters.
17-19

Goals of this investigation
In the present study, we have assessed CV and autonomic functions in FDR of diabetic patients by HRV and BPV analysis, in addition to the assessment by conventional cardiac autonomic function tests (AFT). Furthermore, we have analyzed the association of BRS with SVI and CV risks in FDR of Type 2 diabetics.
MATERIALS AND METHODS
Study design and subjects
After obtaining the approval of Research Council and Institutional Ethics Committee, of Jawaharlal Institute of Post-graduate Medical Education and Research (JIPMER), Puducherry, India, 194 subjects were recruited for this cross-sectional study from undergraduate medical and paramedical courses of JIPMER of 2013-2014 batches. They were classifi ed into two groups. 1. Control group (n = 115): Normal healthy subjects without a family history of diabetes. 2. Study group (n = 79): Normal healthy FDR of patients with Type 2 diabetes mellitus. Subject of the study group (FDR of Type 2 diabetics) was defi ned as the subject having either of the parents or siblings diagnosed to have Type 2 diabetes mellitus for at least 1 year and receiving treatment for the same. This was done as part of a hypertension-diabetes research project, in which family history of diabetes was one of the questionnaires in the data sheet. The subjects were also interviewed, and hospital records examined to confi rm the presence of diabetes in their family.
All subjects were examined clinically by a physician to rule out the presence of any acute or chronic illness. Healthy subjects (subjects without illness) were included in the study. Subjects receiving any medication, subjects with history of diabetes, smoking, hypertension, and hypertensive patients receiving medication were excluded from the study. As the level of physical fi tness is a major determinant of sympathovagal tone, 20 subjects performing regular athletics and body building exercises were excluded from the study.
Recording of anthropometric and HRV parameters
Subjects were asked to report to AFT laboratory of physiology department at about 8 AM following overnight fast. The temperature of the laboratory was maintained at 25°C for all recordings. Their age, height, body weight, and body mass index (BMI) were recorded.
After 15 min of supine rest, electrocardiogram (ECG) was recorded for short-term HRV analysis following the procedures recommended by Task Force 21 using BIOPAC MP-100 data-acquisition system (BIOPAC Inc., Goleta, CA, USA). For the purpose, ECG electrodes were connected and lead II ECG was acquired at a rate of 1000 samples/s during supine rest using BIOPAC MP-100, continuously for 10 min. Data were transferred from BIOPAC to a windows-based personal computer (PC) with AcqKnowledge software version 3.8.2 (BIOPAC Inc., Goleta, CA, USA). Ectopics and artifacts were removed from the recorded ECG. The RR tachogram was extracted from the edited ECG using the R-wave detector in the AcqKnowledge software. HRV analysis was carried out using the HRV analysis software version 1.1 (Bio-signal Analysis group, Kuopio, Finland). Frequency-domain indices of HRV such as total power (TP), normalized low-frequency power (LFnu), normalized high-frequency power (HFnu), ratio of low-frequency to high-frequency power (LF-HF ratio), and time-domain indices such as the square root of the mean of the sum of the squares of the differences between adjacent NN intervals (root mean square successive difference [RMSSD]), standard deviation of normal to normal (SDNN) interval, number of interval differences of successive NN intervals >50 ms (NN50) and the proportion derived by dividing NN50 by the total number of NN intervals (pNN50) were recorded.
Recording of CV parameters and BRS
The CV parameters and BRS were measured by continuous BPV method using Finapres (Finometer version 1.22a, Finapres Medical Systems, Amsterdam, The Netherlands); a non-invasive continuous hemodynamic CV monitor based on the principle of measurement of fi nger arterial pressure with the volume clamp technique of Penaz and the Physical criteria of Wesseling. 22 In this method, the brachial artery pressure measured was the reconstructed pressure from the fi nger pressure, estimated through generalized waveform inverse modeling and generalized level correction. The subjects were asked to lie down, and the brachial cuff of fi napres was tied around the mid-arm about 2 cm above the cubital fossa and the fi nger cuff of small, medium or large size were tied around the middle phalanx of the middle fi nger depending on the fi nger width. For the height correction, two sensors were placed, one at the heart level and another at the fi nger level. The recordings were obtained following connection of cables of the cuffs to the Finometer, after ten minutes of supine rest. The "return to fl ow calibration and the physical" was done for the level correction between the brachial and fi nger pressure during the initial 5 min of the recordings. Following this, the continuous blood pressure (BP) recording was done for a period of 10 min.
The reconstructed brachial pressure was acquired through a PC based data acquisition system (Finapres Medical Systems BV, Amsterdam, The Netherlands). The parameters recorded from the reconstructed brachial pressure tachogram were heart rate (HR), systolic BP, diastolic BP, mean arterial pressure (MAP), rate-pressure product (RPP), interbeat interval, left ventricular ejection time (LVET), stroke volume (SV), cardiac output, total peripheral resistance (TPR), and BRS.
Recording of AFT parameters
Three conventional AFTs were performed following the standard procedures. 23 
HR and BP response to standing
The BP and ECG were recorded in the supine position. The subject was instructed to attain standing posture in 3 s. The ECG was continuously recorded during the procedure. The BP was recorded every 40 s by automatic BP monitor (Omron, SEM-1, Kyoto, Japan) until 5 th min. The 30:15 ratio (ratio of maximum RR interval at 30th beat to minimum RR interval at 15 th beat following standing) was calculated.
HR response to deep breathing
The subject in a sitting posture, HR, and respiration monitoring was done from ECG recording and stethographic respiratory tracings recorded on the multichannel polygraph (Nihon-Kohden, London, UK). A baseline recording of ECG and respiration was taken for 30 s. The subject was asked to take slow and deep inspiration followed by slow and deep expiration such that each breathing cycle lasted for 10 s, consisting of 6 breathing cycles/min. E: I ratio (ratio of average RR interval during expiration to average RR interval during inspiration in six cycles of deep breathing) was calculated from ECG tracing.
BP response to isometric handgrip
The baseline BP was recorded. The subject was asked to press handgrip dynamometer at 30% of maximum voluntary contraction for 2 min. The BP was recorded at 1 st and 2 nd min of contraction. ∆DBP IHG (maximum rise in diastolic BP above baseline) was noted.
Estimation of fasting blood glucose (FBG)
FBG was estimated by glucose-oxidase method using glucometer (LifeScan Inc., Milpitas, CA, USA), following the fi nger prick technique.
Data analysis
SPSS version 13 (SPSS Software Inc., Chicago, IL, USA) and GraphPad InStat software (GraphPad Software Inc., San Diego, CA, USA) were used for statistical analysis. All data were expressed as mean ± SD. Normality of data was tested by Kolmogorov-Smirnov test. For parametric data, the level of signifi cance between the groups was tested by Student's unpaired t-test and for non-parametric data Welch's corrected t-test was used. The association of BRS with BMI and CV parameters was assessed by Pearson's correlation analysis. The independent contribution of BMI, basal heart rate (BHR), LF-HF ratio, and prehypertension status to BRS was assessed by multiple regression analysis. Independent prediction of BRS to cardiac risk (increased RPP) was determined by bivariate logistic regression. The P <0.05 was considered as statistically signifi cant.
RESULTS
There was no signifi cant difference in age (P = 0.1178) between the subjects of the control group and study group ( Table 1) . The BMI, HR, systolic BP (SBP), diastolic BP (DBP), MAP, RPP, SV, LVET, cardiac output and TPR of the study group subjects were significantly more (P < 0.0001) compared to that of the control group subjects (Table 1) . Interbeat interval and BRS were signifi cantly decreased (P < 0.0001) in the study group. Among the frequency domain indices of HRV, TP, HF, and HFnu were signifi cantly reduced (P < 0.0001) and LF, LFnu, and LF-HF ratio were signifi cantly increased (P < 0.0001) in the study group subjects compared to the control group subjects. All the time domain indices (RMSSD, SDNN, NN50, and pNN50) were signifi cantly less (P < 0.0001) in the study group subjects compared to that of the control group subjects. The E: I ratio was signifi cantly decreased, and ΔDBP IHG and 30:15 ratio were signifi cantly increased (P < 0.0001) in the study group subjects (Table 1) .
FBG was signifi cantly high (P < 0.0001) in the study group subjects compared to that of the control group subjects (Table 1) .
Though there was no signifi cant correlation of BRS with any of the parameter in the control group, the correlation of BMI, CV parameters and LF-HF ratio with BRS was signifi cant in the study group (Table 2) .
Multiple regression analysis revealed signifi cant individual contribution of BHR, LF-HF ratio and pulmonary prehypertension status, but not BMI to BRS in the study group (Table 3) . Bivariate logistic regression ( 
DISCUSSION
In the present study, BRS of the study group was signifi cantly reduced ( Table 1) indicating attenuation of CV health of FDR of Type 2 diabetics, as decreased BRS has been reported to be associated with CV morbidity. 24, 25 Further, it has been recently reported that decrease in BRS can predict CV events in Type 2 diabetics. 26, 27 Furthermore, it has been documented earlier that decrease in BRS predicts cardiac mortality in myocardial infarction patients. 28, 29 Thus, decreased BRS in FDR of Type 2 diabetics as observed in the present study could increase their CV risks and predispose them to adverse CV events. The present study is the fi rst of its kind assessing the status of BRS in FDR of Type 2 diabetics. The decrease in BRS was signifi cantly correlated with RPP (Table 3 ) and had signifi cant prediction of RPP (Table 4) . RPP is a measure of myocardial workload and oxygen consumption, and increase in RPP is considered as a potential CV risk. 30 These fi ndings indicate that decreased BRS is linked to increased RPP in FDR of Type 2 diabetics. Moreover, SBP, DBP, and MAP in the study group were signifi cantly high compared to the control group (Table 1) , further indicating poor CV health in FDR of Type 2 diabetics as high normal BP has been reported to increase the risk of CV diseases. 31, 32 Moreover, BRS had independent prediction of prehypertension status in the study group subjects (Table 3) .
TPR was signifi cantly more in the study group subjects (Table 1) . TPR, an indicator of sympathetic vasoconstrictor tone has been suggested as a predictor of CV disease risk in individuals who had more body size at birth. 33 Furthermore, TPR has been directly correlated with ventricular hypertrophy in hypertensives. 34 As an increase in TPR was signifi cantly correlated with BRS in the study group subjects (Table 2) , we presume the association of BRS to potential cardiac morbidities in these subjects. Moreover, SV and cardiac output were increased, and LVET was decreased in the study group, further highlighting the increased hemodynamic stress in FDR of Type 2 diabetics.
Arterial baroreceptors play a central role in BP regulation in response to various stimuli through alteration in both sympathetic and vagal activities, and therefore assessment of BRS provides the state of SVI in various CV disease states. 19 In the present study, BRS was significantly correlated with LF-HF ratio of HRV ( Table 2 ). The LF-HF ratio was signifi cantly increased in the study group (Table 1) indicating sympathetic accentuation and vagal inhibition in FDR of Type 2 diabetics as increase in LF-HF ratio represents facilitation of sympathetic drive and inhibition of vagal drive to the heart 15,21 LF-HF ratio is considered as a sensitive measure of SVI in various clinical disorders 8, 9, 15, 21 Independent association of BRS with LF-HF ratio (Table 3) confi rms the presence of SVI and contribution of SVI to CV risks in FDR of Type 2 diabetics. This corroborates with the fi ndings of our recent report, 14 in which we did not assess cardiac parameters and BRS.
Findings of the present study demonstrate that the SVI in FDR of Type 2 diabetics is due to alterations in both sympathetic and parasympathetic activities. Increase in sympathetic activity was confi rmed by higher LFnu in the study group subjects (Table 1) , as increase in LFnu refl ects increased cardiac sympathetic drive. 15, 21 Inhibition of parasympathetic activity in these subjects was demonstrated by a decrease in HFnu, as decreased HFnu represents decreased vagal modulation of cardiac drive, 15, 21 This was further confi rmed by decreased time-domain indices of HRV in the study group, as time-domain indices represent parasympathetic modulation of cardiac activity. 15, 21 Among HRV indices, RMSSD exclusively refl ects vagal modulation of HR on a short-term basis and is considered as an important indicator of parasympathetic tone. 21 Signifi cantly decreased RMSSD in the study group (Table 1) confi rms poor cardiac vagal control in FDR of diabetic patients.
In addition, increase in ΔDBP IHG in the study group subjects indicates increased sympathetic reactivity in response to isometric handgrip test in FDR of Type 2 diabetics, as ΔDBP IHG refl ects the state of sympathetic reactivity. 23 Increase in 30:15 ratio and decrease in E: I ratio represent decreased parasympathetic reactivity as these two ratios refl ect modulation of vagal reactivity in response to orthostatic stress and deep breathing, respectively. 23 Thus, fi ndings of the present study demonstrate SVI in FDR of Type 2 diabetics is due to increased sympathetic tone and reactivity and decreased vagal tone and reactivity.
The TP of HRV was signifi cantly decreased in the study group subjects (Table 1) representing a substantial decrease in HRV in FDR of Type 2 diabetics as TP represents the quantum of HRV spectrum. 15, 21 Recently, decrease in TP of HRV has been observed to be associated with sudden cardiac death and cardiac morbidities. 8, 9, 35, 36 Thus, decreased HRV in FDR of diabetics patients makes them vulnerable to adverse CV events. Further, BHR was signifi cantly high in these subjects (Table 1) . Resting HR is an index of parasympathetic tone, 23 and increased BHR has been reported to be associated with increased CV risks. 37 As BHR was signifi cantly correlated with BRS (Table 2) and had independent association with BRS, the CV risks mediated through increased BHR in FDR of Type 2 diabetics are linked to the decrease in BRS.
Overweight is common in individuals with family history of diabetes. 38 In the present study, BMI was more in the study group compared to the control group (Table 1) . Though BMI had signifi cant correlation with BRS in the study group (Table 2) , it had no independent association with BRS, demonstrated by multiple regression analysis (Table 3) . Therefore, though BMI is associated with BRS in FDR of Type 2 diabetics, it does not appear to independently contribute to CV risks in these subjects.
FBG was signifi cantly high in the study group subjects compared to that of control subjects ( Table 1 ), indicating that the FDR of Type 2 diabetics are prone to develop diabetes. The limitation of the study is that we have not estimated the plasma insulin, and not assessed insulin resistance, dyslipidemia and oxidative stress that could contribute to SVI in FDR of Type 2 diabetics. Nevertheless, the results of the present study indicate the presence of SVI in the form decreased BRS and increased LF-HF ratio representing increased sympathetic and decreased parasympathetic activity in young FDR of Type 2 diabetics. The CV risk factors such as resting tachycardia, decreased TP of HRV, increased RPP, increased prehypertension status and decreased BRS were prominent in these subjects that were linked to decrease in baroreceptor sensitivity in FDR of Type 2 diabetics. Future studies should assess if restoration of sympathovagal homeostasis attained by non-pharmacological means such as yoga-relaxation would reduce the CV risks in the subjects, as practice of such techniques has been reported to restore sympathovagal balance. 39 
